MoonLake Immunotherapeutics (MLTX)

52.17 +0.29 (+0.56%) USD  |  NASDAQ  |  Dec 20, 16:00
52.27 +0.10 (+0.19%) After-Hours: 20:00
More

MoonLake Immunotherapeutics Max Drawdown (5Y)

Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for MLTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Max Drawdown Definition

View Max Drawdown Definition
Start Trial

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Novartis AG 25.84%
AC Immune SA 89.55%
CRISPR Therapeutics AG 81.61%
Addex Therapeutics Ltd --
NLS Pharmaceutics Ltd --